trinitrobenzenesulfonic acid has been researched along with d-jnki-1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chromik, AM; Dierck, F; Eminel, S; Gavrilova, O; Herdegen, T; Kersting, S; Laukevicience, A; Leuschner, I; Reinecke, K; Roessner, W; Rosenstiel, P; Sina, C; Waetzig, V | 1 |
1 other study(ies) available for trinitrobenzenesulfonic acid and d-jnki-1
Article | Year |
---|---|
The JNK inhibitor XG-102 protects against TNBS-induced colitis.
Topics: Analysis of Variance; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Bcl-2-Like Protein 11; Blotting, Western; Caspase 3; CD3 Complex; Colitis, Ulcerative; Fas Ligand Protein; Fluorescent Antibody Technique; Gene Expression Regulation; Immunohistochemistry; Immunoprecipitation; JNK Mitogen-Activated Protein Kinases; Membrane Proteins; Mice; Peptides; Proto-Oncogene Proteins; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Weight Loss | 2012 |